
Monte Rosa Therapeutics (GLUE)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy GLUE Stock
Start investing in GLUE
About Monte Rosa Therapeutics (GLUE)
Market cap | $302.01M |
Today's volume | 380.75K |
Revenue (TTM) | $159.49M |
Avg. daily volume | 666.09K |
EBITDA (TTM) | $6.14M |
Open | $4.88 |
Price / earnings ratio | 73.07x |
Today's range | $4.74 - $5.01 |
Debt / equity | 15.21x |
52 week range | $3.21 - $12.4 |
5 year debt / equity | -16.3x |
Beta (LTM) | 1.44x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 5.61x |
Ex-dividend date | — |
Next earnings | Aug 7, 2025 |
Dividend payable date | — |
GLUE Stock Rating
GLUE Stock News
View all



Frequently Asked Questions (FAQ)
How to buy GLUE stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in GLUE stock
Navigate to the Explore page. Then, type GLUE into the search bar. When you see GLUE stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased GLUE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Monte Rosa Therapeutics Stock Earnings
The value each GLUE share was expected to gain vs. the value that each GLUE share actually gained.
GLUE (GLUE) reported Q1 2025 earnings per share (EPS) of $0.57, beating estimates of -$0.32 by 278.12%. In the same quarter last year, GLUE's earnings per share (EPS) was -$0.53. GLUE is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of $0.